Eckelman Brendan P.
SEC CIK 1766433 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | CSO | 40.0K | — | — | 1 | 2024-05-29 | 2024-05-29 |
Most active insiders at INBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Viking Global Opportunities Parent GP LLC | 10% | — | $11.29M |
| 2 | Lappe Mark | CEO, Dir | $2.65M | — |
| 3 | Kayyem Jon Faiz | Dir | $1.57M | — |
| 4 | FORSYTH DOUGLAS | Dir | $286.6K | — |
| 5 | MANHARD KIMBERLY | Dir | — | $279.0K |
Eckelman Brendan P. made no open-market trades at INBX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-05-30 | 2024-05-29 | INBX | Inhibrx Biosciences, Inc. | Eckelman Brendan P. | CSO | A - Grant | — | +513.9K | 40.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations